Profil
Dr. Ron Hart is an Advisor at SAIL Capital Partners LLC.
He is an internationally recognized scientist, scholar and expert in business acceleration strategies for emerging growth companies.
He is the former Chief Scientist and Executive Director of the FDA’s National Center for Toxicology Research and was the first person in the history of the FDA to be named “distinguished scientist in residence.” In addition, he was an author of the Federal Technology Transfer Act of 1986 and a co-founder of the Korean Institute of Science and technology.
Dr. Hart received his Ph.D.
in physiology and biophysics from the University of Illinois in 1971.
Ehemalige bekannte Positionen von Ron Hart
| Unternehmen | Position | Ende |
|---|---|---|
SAIL Capital Partners LLC
 SAIL Capital Partners LLC Investment ManagersFinance SAIL Capital Partners LLC (SAIL Capital Partners) is a venture capital firm founded in 1999 by Walter Schindler. The firm is headquartered in Irvine, California. | Private Equity Investor | - |
Ausbildung von Ron Hart
| University of Illinois | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
SAIL Capital Partners LLC
SAIL Capital Partners LLC Investment ManagersFinance SAIL Capital Partners LLC (SAIL Capital Partners) is a venture capital firm founded in 1999 by Walter Schindler. The firm is headquartered in Irvine, California. | Finance |
